By Finance Pulse in earnings —

Nymox Pharmaceutical Corp. Posts Q3 Loss of $716,000

Nymox Pharmaceutical Corp. reports a Q3 loss of $716,000, equivalent to 1 cent per share. Discover the financial performance and insights into the company's future.

A sleek and modern financial chart with red downward arrows symbolizing loss, set against a backdrop
Nymox Pharmaceutical Corp. Posts Q3 Loss of $716,000

Nymox Pharmaceutical Corp. reported a Q3 loss of $716,000, translating to a loss of 1 cent per share.

Source